New South Wales, Australia

Robert Lindsay Raison

This inventor holds 3 USPTO granted patents and 2 published patent applications, plus 1 CIPO patent. Top assignee: Immune System Therapeutics Ltd. Active years: 2008-2010.

IDiyas Innovation Intelligence. (2026). Inventor Profile: Robert Lindsay Raison. Retrieved from https://idiyas.com/inventor/robert-lindsay-raison

Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile

USPTO Granted Patents = 3 

% Patents Active = 100.0


Average Co-Inventor Count = 3.0

ph-index = 2

Forward Citations = 11(Granted Patents)


Location History:

  • Pennant Hills, AU (2008)
  • MacMaster's Beach, AU (2009)
  • New South Wales, AU (2010)

Company Filing History:


Years Active: 2008-2010

Loading Chart...
Loading Chart...
3 patents (USPTO):Explore Patents

Title: The Innovative Contributions of Robert Lindsay Raison

Introduction

Robert Lindsay Raison is a notable inventor based in New South Wales, Australia. He has made significant contributions to the field of medical treatments, particularly in the area of cancer therapy. With a total of 3 patents to his name, Raison's work focuses on innovative methods for treating multiple myeloma.

Latest Patents

Raison's latest patents include a groundbreaking method for treating multiple myeloma. This invention relates to methods for inducing apoptosis in myeloma cells through the administration of a K121-like antibody. His research aims to provide new avenues for effective treatment options for patients suffering from this challenging disease.

Career Highlights

Raison is currently associated with Immune System Therapeutics Ltd, where he continues to develop and refine his innovative approaches to cancer treatment. His work has garnered attention in the medical community, highlighting the importance of targeted therapies in oncology.

Collaborations

Raison collaborates with esteemed colleagues, including Rosanne Dorothy Dunn and Boon Hwa Andre Choo. Their combined expertise contributes to the advancement of research in immunotherapy and cancer treatment.

Conclusion

Robert Lindsay Raison's contributions to the field of medical innovation are noteworthy. His dedication to developing effective treatments for multiple myeloma showcases the potential of targeted therapies in improving patient outcomes.

Profile summary based on public USPTO records.
Data Sources: USPTO Patent Grant XML, Patent Center, EPO & CIPO • Normalized by IDiyas Innovation Graph. Methodology & provenance architecturePlease report any incorrect information to [email protected]
Loading…